Skip to Content
Search Menu

Tralokinumab: New treatment for atopic dermatitis

Let Professor of Dermatology Steve Feldman guide you through his take on the therapeutic potential of tralokinumab in the treatment of atopic dermatitis.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Relateret indhold

Giovanni Damiani

A lot of Factors Increase the Comorbidity at Atopic Dermatitis

/ Giovanni Damiani
Atopic dermatitisEADV24 Play the Video 2:19
Sascha D. W. Stave

Safety Is One of the Main Drivers for Atopic Dermatitis Patient Preferences of Treatment

/ Sascha D. W. Stave
Atopic dermatitisEADV24 Play the Video 07:39
Thrasyvoulos Tzellos

AD: Promising Long-Term Safety Profile for Dupilumab in Real-World Data

/ Thrasyvoulos Tzellos
Atopic dermatitisEADV24 Play the Video 02:51

LBA: Lebrikizumab Provides Long-Term Efficacy and Safety in Atopic Dermatitis with a Well-Tolerated Safety Profile

/ Jan Andreasen
Atopic dermatitisEADV24
Anna Sophie Nicolo Belling Krontoft

Conversation Cards for Patients with Atopic Dermatitis

/ Anna Sophie Belling Krontoft
Atopic dermatitisEADV24 Play the Video 2:56
April Armstrong

Exciting Data on Atopic Dermatitis from EADV 2024

/ April Armstrong
Atopic dermatitisEADV24 Play the Video 04:14
Ida Vittrup

Risk Factors for JAK-Inhibitor Treatment in Atopic Dermatitis

/ Ida Vittrup
Atopic dermatitisEADV23 Play the Video 03:46
Stephan Weidinger

New Treatments for Atopic Dermatitis to Come

/ Stephan Weidinger
Atopic dermatitisEADV23 Play the Video 2:57
Stephan Weidinger

New Insights into Type 2 Inflammation in Atopic Dermatitis

/ Stephan Weidinger
Atopic dermatitisEADV23 Play the Video 2:00
Back to top